Correlation Between Cullinan Oncology and PTC Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and PTC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and PTC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and PTC Therapeutics, you can compare the effects of market volatilities on Cullinan Oncology and PTC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of PTC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and PTC Therapeutics.
Diversification Opportunities for Cullinan Oncology and PTC Therapeutics
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cullinan and PTC is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and PTC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PTC Therapeutics and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with PTC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PTC Therapeutics has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and PTC Therapeutics go up and down completely randomly.
Pair Corralation between Cullinan Oncology and PTC Therapeutics
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the PTC Therapeutics. In addition to that, Cullinan Oncology is 1.2 times more volatile than PTC Therapeutics. It trades about -0.15 of its total potential returns per unit of risk. PTC Therapeutics is currently generating about 0.15 per unit of volatility. If you would invest 3,992 in PTC Therapeutics on September 1, 2024 and sell it today you would earn a total of 396.00 from holding PTC Therapeutics or generate 9.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. PTC Therapeutics
Performance |
| Timeline |
| Cullinan Oncology LLC |
| PTC Therapeutics |
Cullinan Oncology and PTC Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and PTC Therapeutics
The main advantage of trading using opposite Cullinan Oncology and PTC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, PTC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PTC Therapeutics will offset losses from the drop in PTC Therapeutics' long position.| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
| PTC Therapeutics vs. Krystal Biotech | PTC Therapeutics vs. Sarepta Therapeutics | PTC Therapeutics vs. Iovance Biotherapeutics | PTC Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |